首页> 美国卫生研究院文献>Cell Regulation >Factors Controlling Fibroblast Growth Factor Receptor-1s Cytoplasmic Trafficking and Its Regulation as Revealed by FRAP Analysis
【2h】

Factors Controlling Fibroblast Growth Factor Receptor-1s Cytoplasmic Trafficking and Its Regulation as Revealed by FRAP Analysis

机译:FRAP分析揭示了控制成纤维细胞生长因子受体1的细胞质贩运的因素及其调控。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Biochemical and microscopic studies have indicated that FGFR1 is a transmembrane and soluble protein present in the cytosol and nucleus. How FGFR1 enters the cytosol and subsequently the nucleus to control cell development and associated gene activities has become a compelling question. Analyses of protein synthesis, cytoplasmic subcompartmental distribution and movement of FGFR1-EGFP and FGFR1 mutants showed that FGFR1 exists as three separate populations (a) a newly synthesized, highly mobile, nonglycosylated, cytosolic receptor that is depleted by brefeldin A and resides outside the ER-Golgi lumen, (b) a slowly diffusing membrane receptor population, and (c) an immobile membrane pool increased by brefeldin A. RSK1 increases the highly mobile cytosolic FGFR1 population and its overall diffusion rate leading to increased FGFR1 nuclear accumulation, which coaccumulates with RSK1. A model is proposed in which newly synthesized FGFR1 can enter the (a) “nuclear pathway,” where the nonglycosylated receptor is extruded from the pre-Golgi producing highly mobile cytosolic receptor molecules that rapidly accumulate in the nucleus or (b) “membrane pathway,” in which FGFR1 is processed through the Golgi, where its movement is spatially restricted to trans-Golgi membranes with limited lateral mobility. Entrance into the nuclear pathway is favored by FGFR1's interaction with kinase active RSK1.
机译:生化和微观研究表明,FGFR1是跨膜和可溶性蛋白,存在于细胞质和细胞核中。 FGFR1如何进入细胞质并随后进入细胞核以控制细胞发育和相关基因活性已成为一个引人注目的问题。对FGFR1-EGFP和FGFR1突变体的蛋白质合成,细胞质亚区室分布和运动的分析表明,FGFR1以三个独立的群体形式存在(a)一种新合成的,高度移动的,非糖基化的胞质受体,其被布雷菲德菌素A耗尽并且位于ER外部-高尔基体腔,(b)布雷菲德菌素A增加了缓慢扩散的膜受体,并且(c)固定的膜池。RSK1增加了高度可移动的胞质FGFR1群体,其总体扩散速率导致FGFR1核积累增加,并与RSK1。提出了一种模型,其中新合成的FGFR1可以进入(a)“核途径”,其中非糖基化受体从高尔基前体产生,产生高度可移动的胞质受体分子,并迅速积聚在细胞核中;或(b)“膜途径” ”,其中FGFR1通过高尔基体加工,其运动在空间上仅限于横向迁移率受限的反式高尔基体膜。 FGFR1与激酶活性RSK1的相互作用有助于进入核途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号